CLOSTRIDIOIDES DIFFICILE INFECTION RECURRENCE

Clinical trials for CLOSTRIDIOIDES DIFFICILE INFECTION RECURRENCE explained in plain language.

Never miss a new study

Get alerted when new CLOSTRIDIOIDES DIFFICILE INFECTION RECURRENCE trials appear

Sign up with your email to follow new studies for CLOSTRIDIOIDES DIFFICILE INFECTION RECURRENCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 4 Not yet recruiting 1 Completed 1

Trial aims to stop deadly gut infection in High-Risk patients

Disease control Completed

This study tested if adding the drug bezlotoxumab to standard care could prevent severe outcomes in patients with a dangerous C. difficile gut infection. It focused on 44 patients identified as high-risk using a special score based on their genes, blood tests, and gut bacteria. T…

Matched conditions: CLOSTRIDIOIDES DIFFICILE INFECTION RECURRENCE

Phase: PHASE2 • Sponsor: Hellenic Institute for the Study of Sepsis • Aim: Disease control

Last updated Mar 23, 2026 15:15 UTC

CLOSTRIDIOIDES DIFFICILE INFECTION RECURRENCE

Get alerted when new CLOSTRIDIOIDES DIFFICILE INFECTION RECURRENCE trials appear

Trial aims to stop deadly gut infection in High-Risk patients